|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Health Policy Problem Solver: Fumie Griegoover 8 years ago
Dealmaking in 2017: Striking a Balanceover 8 years ago
Beyond the Science: Commercial Implications From ASCO 2017over 8 years ago
News Spotlight: Pharmaover 8 years ago
Pharma’s Marijuana Makeoverover 8 years ago
The 'Hear' and Now for Pharma and Social Mediaover 8 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abuseover 8 years ago
Syncing Social Media With Value-Care Modelover 8 years ago
AI-based Social Listening as Aid to Pharmacovigilanceover 8 years ago
Country Report: IndonesiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
5